• Skip to primary navigation
  • Skip to main content
  • Skip to footer
NICO CorporationSecondary logo

NICO Corporation

Dedicated to revolutionizing minimally invasive neurosurgery

  • Home
  • Patients
  • Professionals
    • Our Capabilities
    • Our Integrated System
    • Our Surgical Focus
    • Our Impact
    • Published Data
    • Investigator Initiated Study Program
      • IIS Program Overview
      • IIS Areas of Interest (AOIs)
    • Donation Request
    • Global Distribution
    • NICO Technologies for Animal Health
    • Neurosurgeon Education
  • Company
    • Our Mission
    • Our Leadership Team
    • News & Events
    • Careers
  • LinkedIn
  • Twitter
  • YouTube

News & Events

Home » News & Events

Upcoming Events

2023 – AANS Annual Meeting February 14, 2023
2023 – ACVIM Forum February 14, 2023
2023 – Subcortical Surgery Group Annual Meeting February 14, 2023
2023 – Annual Meeting of the Congress of Neurological Surgeons August 19, 2022
2023 – American Association for Laboratory Animal Science National Meeting August 18, 2022

Press Releases

New GBM Study PRESERVE Receives $250,000 Grant from NICO Corporation March 15, 2023
NICO Raises $12.5 Million in Oversubscribed Investment Round October 27, 2022
Unique Partnership Seeks to Advance Precision Medicine Options for Deadly GBM Brain Tumors October 10, 2022
First Adaptive Hemorrhagic Stroke Trial Completes Enrollment October 6, 2022
NICO and Elite Medical “Dream Team” Form Oncology Tissue Advisory Board September 8, 2022
NICO Announces New Distributor for Australia and New Zealand Markets July 18, 2022
NICO Secures New Patent Approvals Supporting Neurosurgical Brain Access Solutions May 15, 2022
New Technology Enables Option for Neurosurgeons to Avoid Pinning Patients’ Heads for Brain Surgery March 3, 2022
Extensive Patent Estate Protects NICO’s Leadership Position in Minimally Invasive Neurosurgery January 30, 2022
Brain and Spinal Tumors Glow with Advanced Light Technology December 2, 2021
NICO Launches New Xenon Light Technology Enabling Enhanced Visualization in Minimally Invasive Neurosurgery October 21, 2019
Neurosurgery Medical Device Maker, NICO Corporation, Expands Globally with International Training Course During World Stroke Meeting in Spain June 3, 2019
New Evidence Shows Brain Recovery after Traumatic & Spontaneous Intracerebral Hemorrhage using NICO Minimally Invasive BrainPath Approach April 23, 2019
NICO Completes $12.5 Million Capital Raise Supported by Current Shareholders November 19, 2018
NICO Awards First Investigator Initiated Study Grant to Mayo Clinic November 14, 2018
Viz.ai and NICO Announce Collaboration to Speed Patient Recruitment in the ENRICH Study November 14, 2018
Multi-Center Study Shows Improved, Stable Clinical Outcomes in 96% of Patients with Brain METs October 9, 2018
NICO Launches Investigator Initiated Study Program to Increase Scientific Data Supporting Minimally Invasive Neurosurgery August 9, 2018
NICO Corp. Adds to Strong Intellectual Property Portfolio of 200+ with New Patent Issued Around Revolutionary BrainPath Technology July 17, 2018
Global Healthcare Senior Executive Joins NICO Corp. Board of Directors June 19, 2018
Accomplished CEO & Entrepreneur of the Year Joins NICO Corp. Board of Directors June 6, 2018
Early Intervention of Hemorrhagic Stroke Trial Reaches 100 Patients May 31, 2018
Former Neurosurgery Chairman of Henry Ford Health System, Dr. Mark Rosenblum, Joins NICO Corporation Board of Directors May 29, 2018
New Published Evidence for Deadly High-Grade Gliomas Linked to Improved Survival May 22, 2018
NICO Continues to Innovate with Smallest Trans-Sulcal Brain Access Tool in the World May 1, 2018
NICO Corporation Appoints New Vice President of Sales January 18, 2018
Inclusion of NICO BrainPath Approach for Minimal Access Surgery into Pilot ERAS Protocol Supports Possibility for Improved Patient Outcomes October 10, 2017
Data on Largest Adult Patient Cohort Shows Diversity, Utility of NICO BrainPath® for Treatment of Tumors, Hemorrhages Located in Deep Subcortical Regions October 9, 2017
New Study Reveals Nearly $12,000 per Patient Economic Benefit for Hospitals Using New Technology for Brain Tumor Removal and Stroke Treatment August 28, 2017
High Interest in Early Removal of Hemorrhagic Stroke Leads to Doubling Number of Clinical Trial Sites July 27, 2017
NICO Announces CE Mark for BrainPath® Non-Disruptive Cranial Access Technology April 3, 2017
Top Academic Healthcare Centers Presenting New Surgical Options for Stroke Patients February 22, 2017
FDA Grants New Clearance for Brain Surgery Technology January 23, 2017
Neurosurgery Device Maker Completes $15 Million Capital Raise to Address Increasing Market Demand of New Technologies for Tumor and Stroke February 23, 2016
NICO Announces Hemorrhagic Stroke Trial Lead by Emory University and Grady Memorial January 13, 2016
NICO Announces Collaboration with Hitachi Aloka Medical to Create Improved Visualization for Difficult to Reach Brain Tumors September 28, 2015
NICO Receives Additional FDA Clearance for Specific BrainPath® Indications for Subcortical Access to Brain Tumors, Cysts and Vascular Disease July 27, 2015
NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions May 5, 2015
Multi-Center Intracerebral Hemorrhage Pilot Study Yields Statistically Significant Data for Early Intervention February 12, 2015
NICO BrainPath® Medical Device for Safely Accessing the Brain Wins Indiana Innovation Award September 3, 2014

Media Coverage

Spectrum Health uses NICO technology for minimally invasive removal of benign cavernoma July 29, 2019
When the Stars Align: Trained Surgeon + New Technology & Early Intervention Save Life of Patient with Hemorrhagic Stroke June 1, 2017
New Technology in Treating Hemorrhagic Stroke: Is a New Gold Standard on the Horizon? May 10, 2017
Stroke Champ Meets a Champ March 14, 2017
Trial on Early Intervention of Hemorrhagic Stroke Advances January 17, 2017
“Miracle Patient” Undergoes Revolutionary Surgery September 26, 2016
New procedure allows doctors to navigate delicate brain tissue to treat bleeding strokes August 9, 2016
Studies: Hemorrhagic Stroke Patients Have Second Chance July 13, 2016

Footer

OUR MISSION is SIMPLE

We provide proven and patented technologies that integrate imaging and intervention for a safe, minimally disruptive approach to brain surgery. This integration drives efficiencies for the patient, surgeon and healthcare provider.

Customer Service

 Tel: (317) 660-7118
 Email Us

Follow NICO Here

  • LinkedIn
  • Twitter
  • YouTube
Social Media Links

Search Our Website

privacy policy   ·    terms of use   ·    patents    ·   labeling

Copyright © 2023 · Nico Corporation · NICO Myriad and BrainPath are “tools” not “treatments”. Physicians should use their best judgment and clinical experience when deciding how to use the Myriad and BrainPath. The latest information, including contraindications, warnings and precautions can be obtained by consulting product labeling or your local NICO representative.